Miranda J. Toledano

“In connection with her appointment as Chief Executive Officer, Ms. Toledano will no longer serve as the Company’s Chief Financial Officer (principal financial officer) effective on July 15, 2022.”

“On July 13, 2022, the Board of Directors (the “Board”) of Entera Bio Ltd., a company organized under the laws of the State of Israel (the “Company”), appointed Miranda J. Toledano, one of the Company’s existing directors and the Company’s Chief Business Officer, Chief Financial Officer and Head of Corporate Strategy, as the Company’s Chief Executive Officer (principal executive officer), which appointment became effective on July 15, 2022 concurrently with the effectiveness of the separation from the Company of Dr. Spiros Jamas, as described below.”